This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Explore the proven benefits of zero based budgeting and how it creates accountability and tangible financial outcomes.
22,633 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
AT&T has been through a long turnaround, shedding assets and tightening the balance sheet. This article weighs the ca...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
Brent crude charts flashed a pattern not seen in 36 years, triggering fresh volatility bets. Analysts say the rarity ...
As investors eye Regal Rexnord’s Q1 2026 earnings, the focus turns to demand momentum, margin discipline, and capital...
Delinquencies eased in March to 3.35%, though higher-severity stress remains elevated. FHA loans push delinquency sha...
Mega rounds in drones and AI-driven drug discovery signal big shifts in tech investing. This piece explains the perso...
Housing stocks depression mode is taking hold as major builders and appliance makers slump despite a rising S&P 500. ...
Institutional investors are loading up on two beaten-down software giants as AI infrastructure demand remains solid a...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...
Warren Buffett’s long run outperformed the market for 60 years, driven by durable moats and patient capital. Learn th...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...